Table 1: Estimates of Social Costs of Diabetes in Puerto Rico for the year 20101
1.Dr. Heriberto Marin used estimates for the social costs of Diabetes in the United States as based to generate estimates for Puerto Rico. The source used for the US was the following: United States Economic Cost of Diabetes in the U.S. in 2007, American Diabetes Association, Diabetes Care, Volume 31, Number 3, March 2008. In order to generate the estimates for Puerto Rico the following steps were taken: 1) the number of adult diabetic patients in Puerto Rico by age group was obtained from the BRFSS, 2)the average direct and indirect cost by patient were imputed from the US, 3) costs were aggregated for each age group to generate total costs, 4) figures were inflated to the year 2010 using the price indexes for Puerto Rico, and 5) all figures were adjusted downward using the fact that Medicare payments in Puerto Rico are in average 60% of those in the US.
2.According to the Behavioral Risk Factor Surveillance System (BRFSS) for 2010. http://www.cdc.gov/brfss/
The World Health Organization latest published numbers on diabetes prevalence showed that diabetes is a growing global problem, with high and increasing costs to society and the individual . Mayor pharmaceutical companies are incurring in substantial capital investment responding to what they have recognized as the growing diabetes epidemic. Keeping the diabetes care cost low is of great concern, especially since 80% of people with diabetes live in low to middle-income countries [22,23].